General MedicationsORALGeneric

SUMATRIPTAN SUCCINATE

Standard Dose

50MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview SUMATRIPTAN SUCCINATE is listed in Drugs@FDA under application 077696 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient SUMATRIPTAN SUCCINATE Form and strength TABLET; ORAL - 50MG Sponsor CHARTWELL MOLECULAR Submission history Latest submission status date: 2007-08-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview SUMATRIPTAN SUCCINATE is listed in Drugs@FDA under application 077696 (ANDA). Marketing status: None (Tentative Approval) Active ingredient SUMATRIPTAN SUCCINATE Form and strength TABLET; ORAL - 50MG Sponsor CHARTWELL MOLECULAR Submission history Latest submission status date: 2007-08-27 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.